Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 47,000 full-time employees.  Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. The company is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).

Eli Lilly & Co. terlibat dalam penemuan, pengembangan, pembuatan, dan penjualan produk farmasi. Perusahaan ini berkantor pusat di Indianapolis, Indiana dan saat ini mempekerjakan 47.000 karyawan penuh waktu. Produk kesehatan kardiometaboliknya meliputi Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, dan lainnya; Humulin, Humulin 70/30, dan lainnya; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, dan VERVE-301. Produk onkologi-nya termasuk Cyramza, Erbitux, Tyvyt, dan Verzenio. Produk imunologinya meliputi Ebglyss, Olumiant, Omvoh, dan Taltz. Produk neuro ilmiah-nya termasuk Emgality dan Kisunla. Perusahaan ini, melalui anak perusahaannya, POINT Biopharma Global Inc., terlibat dalam penemuan, pengembangan, dan upaya pembuatan radiopharmaceutical, serta terapi radioligand klinis dan pra-klinis yang sedang dikembangkan untuk pengobatan kanker. Perusahaan ini juga sedang mengembangkan penghambat molekul kecil oral a4b7 integrin untuk penyakit radang usus (IBD).

Eli Lilly

NVIDIA

Apple

Microsoft

Google

Amazon

Broadcom

Meta Platforms

Taiwan Semiconductor

Tesla

Berkshire Hathaway

JPMorgan

Walmart

Oracle

Visa

Exxon Mobil

Johnson & Johnson

MasterCard

Netflix

SPDR S&P500 ETF

AbbVie

ASML

Costco

Palantir

Bank of America

Alibaba

Procter & Gamble

Home Depot

General Electric

Cisco

Coca-Cola

Chevron

Vanguard Total Stock Market ETF

UnitedHealth Group

AstraZeneca

Wells Fargo

Caterpillar

Toyota

Micron Technology

Morgan Stanley

Novartis

Philip Morris

American Express

T-Mobile

Merck

Goldman Sachs

Raytheon Technologies

Abbott

Salesforce

Novo Nordisk

McDonald's

Shell

Royal Bank of Canada

Intuitive Surgical

Invesco QQQ Trust

PepsiCo

Linde PLC

Shopify

Disney

Lam Research

Applied Materials

Uber

Amgen

Citigroup

Intuit

AT&T

NextEra Energy

Verizon

QUALCOMM

Sony

Blackstone

ServiceNow

Charles Schwab

Intel

Danaher

Gilead Sciences

BlackRock

Arista Networks

Banco Santander

Booking Holdings

Accenture

S&P Global

Unilever

Boston Scientific

Texas Instruments

Pfizer

Boeing

Toronto-Dominion Bank

TotalEnergies

Adobe

Progressive

Union Pacific

CrowdStrike

Capital One

Saham Eli Lilly

Tentang Eli Lilly

Statistik Kunci